Clovis Oncology Inc EBITDA margin
Was ist das EBITDA margin von Clovis Oncology Inc?
EBITDA margin von Clovis Oncology Inc ist -151.34%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Clovis Oncology Inc
Unternehmen mit ebitda margin ähnlich Clovis Oncology Inc
- Profound Medical Corp hat EBITDA margin von -152.78%
- Fuelcell Inc hat EBITDA margin von -152.60%
- AusCann Ltd hat EBITDA margin von -152.52%
- AusCann hat EBITDA margin von -152.52%
- Sino Prosper () hat EBITDA margin von -152.20%
- Ceres Power plc hat EBITDA margin von -151.94%
- Clovis Oncology Inc hat EBITDA margin von -151.34%
- Hycroft Mining hat EBITDA margin von -151.15%
- Hallmark Services, Inc hat EBITDA margin von -151.09%
- Kyckr hat EBITDA margin von -150.93%
- Allied Esports Entertainment hat EBITDA margin von -150.84%
- Clear Blue Technologies International hat EBITDA margin von -150.81%
- Kernex Microsystems (India) hat EBITDA margin von -150.76%